Novo Nordisk A/S v. Sanofi-Aventis
1:05-cv-00645
Overview
Parties
Defendant
Aventis Pharma AG NPE (Individual / Inventor)
Represented By
0 Attorneys ListedAventis Pharma Deutschland Gmbh Operating Company
Represented By
4 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Aventis Pharmaceuticals Inc. Operating Company
Represented By
5 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Novak Druce Connolly Bove + Quigg LLP
The Nemours Building, 1007 North Orange Street
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Sanofi-Aventis Operating Company
Represented By
5 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Plaintiff
Novo Nordisk A/S NPE (Individual / Inventor)
Represented By
2 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 6,582,408 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,870,798 P | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6582408
Medical device
|
Filed: 1999-07-08
Issued: 2003-06-24
|
Expired (Term Ended)
Expires: 2019-07-08
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
6
Dispositive
0
Granted
0
Denied
0
Pending / Review
6
Motions by Category
Key Dispositive Motions & Rulings